Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2019 Will Be Testing Period For US FDA's Novel Pre-Cert Paradigm For Digital Health

Executive Summary

In 2019, FDA will be taking steps to perform real-world testing of the effectiveness of its pre-cert program for health software and whether the program can be carried out within the agency's current regulatory authorities. The efforts come after more than a year of development and some pushback about statutory overreach and patient safety.

Advertisement

Related Content

Pre-Cert Program Will Start Off Slow With De Novo Framing, But Big Questions Remain
2018 US Device Approvals: The Year Of De Novos And Digital Health
US Senators Question FDA's Pre-Cert Program Authority, Concerned About Safety
US FDA's Software Pre-Cert Program: Is The Authority On The Books?
Coming Together On Pre-Cert: Digital Health World Engages With FDA To Hash Out Regulatory Future

Topics

Advertisement
UsernamePublicRestriction

Register

MT124466

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel